as investors face another uncertain year for public equities largecap healthcare stocks remain an attractive defensive play they offer a shot at insulating capital from the downturn many still expect to come that thinking buoyed the stock prices of big healthcare companies in 2022 the health care select sector sdpr fund ticker xlv which tracks the healthcare sector was down 46 in 2022 through tuesday’s close beating the broader sp 500 down about 20